Mehuys E, Vervaet C, Remon J P
Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, 9000 Gent, Belgium.
J Control Release. 2004 Feb 10;94(2-3):273-80. doi: 10.1016/j.jconrel.2003.09.018.
The objective of the study was to develop a sustained release system consisting of a hot-melt extruded ethylcellulose pipe surrounding a drug-containing hydroxypropyl methylcellulose (HPMC)-Gelucire 44/14 core, yielding a monolithic matrix system applicable in the domain of sustained drug release. The influence of HPMC substitution type and viscosity grade was investigated through dissolution testing and erosion studies. All sustained release systems showed a nearly constant drug release profile with only 40% of the drug released after 24 h. To achieve complete drug release after 24 h, the core formulation and the dimensions of the hollow pipe were modified. Changing the composition of the core did not result in the intended zero-order drug release. Shortening the length of the ethylcellulose cylinder accelerated drug release, while modifying the diameter did not affect the drug release rate. The drug dissolution profile and the release mechanism were independent of drug solubility. Increasing the drug loading caused a small increase of the drug release rate, but did not alter the release mechanism.
该研究的目的是开发一种缓释系统,该系统由围绕含药羟丙基甲基纤维素(HPMC)-Gelucire 44/14核的热熔挤出乙基纤维素管组成,形成一种适用于药物缓释领域的整体基质系统。通过溶出度测试和侵蚀研究,考察了HPMC取代类型和粘度等级的影响。所有缓释系统均显示出近乎恒定的药物释放曲线,24小时后仅释放40%的药物。为了在24小时后实现药物完全释放,对核心配方和中空管的尺寸进行了修改。改变核心成分并未导致预期的零级药物释放。缩短乙基纤维素圆柱体的长度可加速药物释放,而改变直径则不影响药物释放速率。药物溶出曲线和释放机制与药物溶解度无关。增加药物载量会使药物释放速率略有增加,但不会改变释放机制。